Hangzhou Keyao Pharmaceutical Technology is dedicated to the process development of new drugs and generic drugs, as well as the optimization and industrial scale-up of intermediate processes. The company has successfully industrialized multiple projects, including Omarigliptin, Veliparib, Pimavanserin, Canagliflozin, Dapagliflozin, Empagliflozin, and their intermediates. In the field of new drug process research and registration, the company has collaborated with numerous enterprises through technology transfer and technical participation, with all projects ranking high in the application sequence. Technological innovation, service quality, customers, and employees are the cornerstones of our growth and development! We appreciate the support of our longstanding clients and are committed to delivering the same level of service and quality to create value for new partners. We strive to provide a positive working environment for our employees and offer ample opportunities for career advancement. We welcome talented individuals to join us and build a brighter future together!